Catalyst Wire Dossier Catalyst Wire Dossier

SAR341402

SAR341402 · Sanofi
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAR341402, covering 2019-08-08 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine [Phase 3]

See pricing